Antonio J. Torralba-Sahuquillo

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Recalcitrant folliculitis decalvans treated with baricitinib or upadacitinib: a case series.

Recalcitrant folliculitis decalvans treated with baricitinib or upadacitinib: a case series.

Journal: Clinical and experimental dermatology

Published: December 29, 2025

Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response.

Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response.

Journal: Dermatology and therapy

Published: July 15, 2025

Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors.

Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK Inhibitors.

Journal: International journal of dermatology

Published: July 06, 2025

Risk of infections in patients with psoriasis treated with biologic agents and new oral small molecules: BIOBADADERM registry.

Risk of infections in patients with psoriasis treated with biologic agents and new oral small molecules: BIOBADADERM registry.

Journal: The Journal of investigative dermatology

Published: June 18, 2025

Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares: An Observational, Retrospective, and Multicenter Study of Effectiveness and Safety in Real-World Clinical Practice.

Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares: An Observational, Retrospective, and Multicenter Study of Effectiveness and Safety in Real-World Clinical Practice.

Journal: International journal of dermatology

Published: January 19, 2025

Cutaneous nodules on tattoo as the first manifestation of pulmonary sarcoidosis with extrathoracic involvement.

Cutaneous nodules on tattoo as the first manifestation of pulmonary sarcoidosis with extrathoracic involvement.

Journal: Medicina clinica

Published: November 19, 2024

Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry.

Cardiovascular safety of systemic psoriasis treatments: A prospective cohort study in the BIOBADADERM registry.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 13, 2024

Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study.

Drug survival and safety of biosimilars for treating psoriasis compared with originator adalimumab: a multinational cohort study.

Journal: The British journal of dermatology

Published: September 24, 2024

Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry.

Risk of adverse events of psoriasis treatment with biologic agents and new small molecules-BIOBADADERM Registry.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 21, 2024

Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice.

Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice.

Journal: Actas dermo-sifiliograficas

Published: September 12, 2024

Violaceous plaque in an immunosuppressed patient's leg.

Violaceous plaque in an immunosuppressed patient's leg.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: June 30, 2024

Survival of Interleukin-17 and Interleukin-23 Inhibitors in Patients Previously Treated With a Tumor Necrosis Factor Inhibitor: Analysis of the Spanish Biobadaderm Registry.

Survival of Interleukin-17 and Interleukin-23 Inhibitors in Patients Previously Treated With a Tumor Necrosis Factor Inhibitor: Analysis of the Spanish Biobadaderm Registry.

Journal: Actas dermo-sifiliograficas

Published: May 15, 2024

Showing 1-12 of 68

Last Updated: 09/26/2026